Sec34p/Grd20p has been implicated in endoplasmic reticulum (ER)-to-Golgi transport and/or post-Golgi trafficking events and exists in a protein complex consisting of at least 8 subunits in yeast. Although the mammalian counterpart (Sec34) of Sec34p has been molecularly identified, its role and interacting partners remain undefined. In this study, we have prepared antibodies specifically against the recombinant N-terminal fragment of Sec34 that recognize a polypeptide of about 93 kDa and label the Golgi apparatus. In a well-characterized semi-intact cell assay that reconstitutes transport of the envelope glycoprotein (VSVG) of vesicular stomatitis virus (VSV) from the ER to the Golgi, anti-Sec34 antibodies inhibited the transport in a dose-dependent 
Introduction
Protein transport from the ER to the Golgi in mammalian cells involves several key steps (1-2).
Cargo proteins and components necessary for downstream steps are first exported from the ER exit sites (ERES) via the action of COPII components (3) (4) . COPII vesicles and/or clusters of COPII vesicles are believed to undergo homotypic fusion to form pleiotropic transport intermediates (1, 5) . The ERES and transport intermediates have been collectively referred to as the intermediate compartment (IC) or ER-Golgi intermediate compartment (ERGIC) (2, 6) . The heterotypic fusion of the transport intermediates with the cis-Golgi results in delivery of cargo proteins to the Golgi apparatus. Many proteins originally identified in yeast have now been
shown to participate in ER-to-Golgi transport in mammalian cells (2, 7) and more proteins regulating ER-Golgi transport in mammalian cells are expected to exist. SEC34 and SEC35 were identified as genes whose products are necessary for protein transport from the ER to the Golgi in yeast Sc. cerevisiae (8) . More detailed studies of Sec34p and Sec35p have suggested that they function as components of a protein complex that act as a tethering factor to ensure the proper docking and fusion of transport intermediates with the Golgi apparatus (9) (10) (11) (12) . In addition, the TRAPP protein complex (13) and Uso1p (14) (15) (16) have similarly been shown to function in tethering for the same transport event. Although the spatial, temporal and mechanistic relationships among the Sec34/Sec35p complex, the TRAPP complex, and Uso1p are yet to be fully characterized, the importance of the tethering process in ensuring faithful docking and fusion of transport intermediates with the target compartment is becoming more recognized in several trafficking events (17) (18) (19) . Although the mammalian homologue (Sec34) of Sec34p has been molecularly identified (20) , its role in membrane traffic in mammalian cells remains to be established and its interacting partners remain to be explored.
GTC-90 was purified as a component of a novel protein complex in mammalian cells that is required for intra-Golgi transport in vitro (21) . Although the GTC-90 protein complex is known to include several other different subunits, their identities are unknown and the functional aspects of the GTC-90 complex in other transport events remain to be examined.
Low density lipoprotein (LDL) receptor is responsible for the clearance of serum LDL particles and diverse mutations in its gene are associated with familial hypercholesterolemia (22) . Due to its importance, understanding the pathway and mechanism underlying LDL receptor trafficking has been an active area of cell biology. Genetic approaches have been used to create and identify several mutant lines of Chinese hamster ovary (CHO) cells, including ldlA-ldlI (23) (24) (25) . The genes mutated in some of these mutants (such as ldlA, ldlB, lldC, ldlD, and ldlF) have been identified (26) (27) (28) (29) (30) . Biochemical and cell biological characterizations of ldlBp and ldlCp have revealed that they are components of the same protein complex (28, 30) . Both ldlBp and ldlCp are necessary for maintaining novel structure and function of the Golgi apparatus, although the precise function remains to be investigated.
Using antibodies against the recombinant Sec34 N-terminal fragment, evidence is presented to support a role for Sec34 in ER-to-Golgi transport in mammalian cells. Significantly, the observation that antibodies against Sec34 could co-immunoprecipitate GTC-90, ldlBp and others suggests that Sec34, GTC-90, ldlBp and ldlCp are part of the same protein complex(s) that may regulate diverse aspects of the Golgi functions, including ER-Golgi transport.
Expression constructs for myc epitope-tagged Sec34, Dor1, Cod1, Cod2, ldlBp, and ldlCp Myc-Sec34: Sec34 cDNA in pT7T3D-Pac vector was digested with XhoI and NotI and the resulting fragments was digested with BglI to obtain an approximately 2.5 kb fragment which contains the entire coding region of Sec34. This fragment was blunt-ended and ligated to pDMycneo vector (31) pre-cut with XbaI and blunt-ended. Myc-Cod2: Primer 1 (5'-GAG CTC GAG CGG GCA GAG GGC AGC GGG GAA GTG) and primer 2 (5'-GGC ATC TGC AAC TTG AGC TCT TAT CTC TAA TTT) were used to amplify a 450 bp fragment from KIAA1134 clone and the resulting PCR product was digested with XhoI and SacI. This fragment was ligated to another fragment retrieved by digesting KIAA1134 with SacI and NotI, together with the pDMycneo vector pre-cut with XhoI and NotI. Myc-ldlBp: Primer 3 (5' -GAG CTC GAG CGG GTG GGC GAA CGG TAC) and primer 4 (5' -TAC ACA TGT GGA TCC ATT TCT GCA GC) were used to amplify an approximately 1 kb fragment from KIAA1381 and the resulting PCR fragment was digested with XhoI and BamHI. This was ligated to a fragment retrieved from KIAA1381 by digestion with BamHI and NotI, together with pDMyc-neo vector pre-cut with XhoI and NotI. Myc-ldlCp: Primer 5 (5' -GGC CTC GAG CGG GAG AAA AGT AGG) and primer 6 (5' -GGT CTA GAC GAG AGG CTG CTC TGC TGT TGC) were used to amplify the entire coding sequence of ldlCp from IMAGE clone AI492237 by PCR and the resulting product was digested with XhoI and XbaI and ligated into the corresponding sites of pDMyc-neo vector.
Myc-Dor1 and Myc-Cod1: Plasmids SDOR1M1 and SCOD1M4 which express Dor1 and Cod1, respectively, with triple myc-tags at the C-terminus were kindly provided by Dr. Sean Munro (32) .
Expression and purification of recombinant GST fusion proteins For production of recombinant glutathione-S-transferase (GST) fusion proteins, primer 7 (5'-ATT GGA TCC ATT ATG GCG GAG GCG GCG) and primer 8 (5'-CGG CTC GAG CGG ACT TGT GAG GGT CTG TAG TGT GTT) were used to amplify the coding sequence for residues 1-276 of Sec34.
This PCR product was digested with BamHI and XhoI. Primer 9 (5' -CTC CCG GGT CAT CAG TTA CTG AAA AGG GAT CCT) and primer 10 (5' -CGG CTC GAG CGG TCC ATG AAG ATC TGC) were used to retrieve the region coding for residues 277-552 of Sec34. The PCR product was digested with SmaI and XhoI. Primer 11 (5' -CCC GGA TCC CCC ATG TGG TAT CCT ACG GTT CGA AGA) and primer 12 (5' -CGG CTC GAG CGG TTT AGA AAC TGA CAG CAG AAG) were used to amplify the sequence coding for residues 553-828 of Sec34. This PCR product was digested with BamHI and XhoI. The bacterial expression vector pGEX-4T-1 (Pharmacia Biotech) was digested accordingly and ligated with these PCR fragments. The ligated plasmids were transformed into DH5α cells and ampicillin resistant colonies expressing the GST fusion proteins were screened as described (33) . Purification of GST fusion proteins was performed as described (34) .
Preparation and affinity-purification of Sec34 antibodies 400 µg of GST-Sec34/F1 was emulsified with Freund's complete adjuvant and injected subcutaneously into two local New Zealand White rabbits. Booster injections with the same amount of antigen in Freund's incomplete adjuvant were administered every two weeks. The rabbits were bled ten days after the second and subsequent boosters. For affinity purification, the antiserum was first diluted with an equal volume of PBS and then incubated for 2 hrs at 4°C with GST-coupled to cyanogen bromide-activated Sepharose 4B (Amersham Pharmacia Biotech) to remove antibodies against GST. The flow-through was then incubated overnight at 4°C with GST-Sec34/F1-coupled beads.
The beads were washed extensively and Sec34 specific antibodies were eluted with low pH elution buffer as described (34) .
Immunoblot analysis Proteins were separated by SDS-PAGE and electro-transferred onto Hybond C+ nitrocellulose. The blots were then incubated for one hour at 37°C in blocking buffer (5% skim milk, 5% fetal bovine serum in PBS containing 0.05% . The blots were incubated in blocking buffer containing primary antibodies for one hour at room temperature followed by three washes with PBS containing 0.05% Tween-20 for five minutes each. The blots were then incubated with either goat anti-rabbit or anti-mouse antibody conjugated to horseradish peroxidase (HRP)(Jackson ImmunoResearch). After three washes in PBS containing 0.05% Tween-20, SuperSignal West Pico Chemiluminescence Substrate (Pierce) was added and the blots were processed as according to the manufacturer's protocol. For blocking experiment shown in Fig 2A, 50 µg of proteins extracted from Golgi-enriched membranes or cytosol were electrophoresced and transferred to a filter. After blocking, the filter was immunoblotted with 2 µg of affinity-purified Sec34 antibodies; 2 µg of Sec34 antibodies preincubated with 20 µg of recombinant GST-Sec34/F1, GST-Sec34/F2 or GST-Sec34/F3 separately.
Immunofluorescence microscopy Cells were grown on coverslips overnight to a confluency of 50-80% and rinsed twice with PBSCM and processed as described (34) (35) . 5-10 µg/ml of Sec34 antibodies in fluorescence dilution buffer (PBSCM with 5% normal goat serum, 5% fetal bovine serum and 2% bovine serum albumin, pH 7.6) were used. 0.5 µg of GST-Sec34/F1 was used to neutralize the antibodies.
In vitro ER-Golgi transport using semi-intact cells
The ER-Golgi transport assay using semi-intact cells was a modified assay according to previously reported procedure (7, 36) and performed as follows: Briefly, NRK cells grown on 10-cm Petri dishes as a confluent monolayer were infected with a temperature-sensitive strain of the vesicular stomatitis virus, VSVts045, at 32°C for an hour and then at the restrictive temperature of 40°C for another 2 hours. The cells were then subjected to perforation on ice by hypotonic swelling and scraping. These semi-intact cells were then incubated in a complete assay Hepes, pH7.3, 100 mM KCl, 2 mM EDTA). 50 mg of rat liver cytosol was first incubated with the beads bound with control rabbit IgG in gradient buffer with 0.5% TX-100 for 2 hrs at 4°C.
The supernatant was then incubated with the beads bound to Sec34 antibodies overnight at 4°C.
The beads were then washed three times with gradient buffer containing 0.5% TX-100 and then finally with gradient buffer without TX-100. In Vitro translation and binding experiment TNT T7 Quick Master Mix (Promega) was used for in vitro translation according to manufacturer's protocol. In 100 µl reaction, myc-tagged Sec34 and each of myc-tagged ldlBp, ldlCp, and Cod2 were co-translated for 2 hrs at 30°C. 20 µl of each reaction was used for co-immunoprecipitation with 10 µg of anti-myc antibodies (rabbit polyclonal IgG) (Upstate biotechnology) or 10 µg of anti-sec34 antibodies bound to Protein ASepharose beads in gradient buffer with 0.1% TX-100. After 1 hr at RT, the beads were washed 5 times with gradient buffer with 0.1% TX-100 and analysed by SDS-PAGE and autoradiography together with 2 µg of in vitro translated product (10% starting material).
Transfection and analytic immunoprecipitation

Results
Characterization of antibodies against Sec34 Due to the established role of Sec34p in ER-
Golgi transport in yeast and our general interest in ER-Golgi transport in mammalian cells, we used the amino acid sequence of Sec34p to search for its putative mammalian counterpart by BLAST searches (37) . Several cDNA sequences encoding polypeptides homologous to various regions of Sec34p were uncovered. The complete coding region of human Sec34 was assembled from various cDNAs and confirmed by DNA sequencing (GenBank accession number AF332595). During the course of our work, the molecular identification of human Sec34 was independently reported (20) . Examination of the deduced 828 amino acid sequences suggests that Sec34 could be roughly divided into two regions ( Fig 1A) . The N-terminal one third is highly homologous to counterparts from other species such as yeast, fly and worm and has the potential (particularly residues 126-211) to form coiled-coil structures. The C-terminal two thirds is homologous to EEA1 (Fig 1B) , a well-established tethering factor that regulates endosome fusion (38) . The structural relatedness of Sec34 to a well-defined tethering protein provides some structural evidence for Sec34 to function as a tethering factor. In order to define the functional and biochemical aspects of Sec34, we expressed recombinant Sec34 in three separate fragments (residues 1-276 as Sec34/F1, residues 277-552 as Sec34/F2 , and residues 553-828 as Sec34/F3) fused to GST (Fig 1A) . GST-Sec34/F1 was used to raise antibodies against Sec34. As shown in and 8), suggesting that the antibodies are specific for Sec34 and that Sec34 is present in both cytosolic and membrane fractions. Using these antibodies in immunofluorescence microscopy, Sec34 was seen to be enriched in the Golgi apparatus (Fig 1D, panel a) (20) and suggest that our antibodies are specific for Sec34.
A role for Sec34 in ER-Golgi transport Since evidence for a functional role for Sec34 in ERGolgi transport in mammalian cells is lacking, we investigated the potential transport function of Sec34 by using a modified semi-intact cell assay that reconstitutes protein transport from the ER to the Golgi (see Materials and Methods for details). NRK cells were infected with a temperature sensitive mutant vesicular stomatitis virus (VSV ts045) at 32°C for 1hr followed by incubation at 40°C for 2 hr to accumulate its envelope protein (VSVG) in the ER. Cells were then permeabilized by scraping in hypotonic buffer and used to reconstitute transport of VSVG by supplementing with exogenous rat liver cytosol and an ATP-regenerating system at 32°C.
Transport of VSVG to the Golgi was measured by monitoring the conversion of its endo-H sensitive glycans to endo-H resistant forms of the entire population of ER-arrested VSVG molecules as revealed by immunoblot analysis. There are two advantages in this modified assay as compared to the original protocol (7). The first is that no radioactive materials were used. The other is that, instead of measuring a small fraction (the radiolabeled pool) of total VSVG, this assay measures the synchronized transport to the Golgi of almost all VSVG molecules accumulated in the ER. As shown in Fig 2, VSVG remained as the endo-H sensitive ER form when the transport reaction was performed on ice ( Fig 2A, lane 1; Fig 2B, lane 1) or in the absence of cytosol (Fig 2A, lane 2 ; Fig 2B, lane 2) . Between 60-90% of total VSVG was converted into the endo-H resistant form when the transport assay was conducted in the presence of complete cocktail at 32°C (Fig 2A, lane 3 ; Fig 2B, lane 3) . Addition of antibodies against GST (Fig 2A, lanes 4-6) did not inhibit this transport, while addition of antibodies against Sec34 (Fig 2A, lanes 7-10) inhibited the transport in a dose-dependent manner. Clear inhibition was observed in the presence of 3 µg or more of anti-Sec34 antibodies and the transport was almost completely inhibited by 7 µg of antibodies (Fig 2A, lane 10) . The inhibition by Sec34 antibodies is specific because it could be neutralized by a non-inhibitory amount of GST-Sec34/F1 (Fig 2B, lanes 5 and   7) but not GST (Fig 2B, lanes 4 and 6) . These results suggest that Sec34 is important for ERGolgi transport in mammalian cells.
Co-immunoprecipitation of GTC-90, ldlBp, Dor1 and Cod1 from total cytosol by anti-Sec34
antibodies In order to define the molecular mechanism underlying the action of Sec34, we have performed large-scale immunoprecipitations using rat liver cytosol (Fig 3) . As compared to rabbit supporting the hypothesis that they are part of the mammalian complex. In order to rule out the possibility that some interesting components may be overlooked, we have also analyzed other polypeptides migrating faster than that of IgG heavy chain. These mainly represented abundant cytosolic proteins such as actin, three ribosomal subunits, glyceraldehydes-3-phosphate dehydrogenase (GAPDH), and glutathione peroxidase. In addition, an uncharacterized protein with Genbank accession number XP_34431 was identified. While we can not exlude the possibility that some of these proteins may be involved in Sec34 function, the presence of abundant cytosolic proteins such as actin, GAPDH, and ribosomal proteins in this low molecular weight region indicates that their presence is likely due to non-specific interactions.
Co-immunoprecipitation of ldlCp and Cod2
While our study was in progress, the yeast These results further support our conclusion that they are specifically co-immunoprecipitated by Sec34 antibodies. Importantly, myc-ldlCp (lanes 3 and 4), and myc-Cod2 (lanes 9 and 10) were co-immunoprecipitated by anti-Sec34 antibodies with efficiencies comparable to that observed for myc-ldlBp, myc-Dor1 and myc-Cod1, supporting the notion that these other proteins are indeed subunits of the same mammalian complex(s). Consistent with our interpretation that polypeptides with sizes smaller than that of IgG heavy chain were present in the Sec34
immunoprecipitates due to their high abundances and non-specific interactions, myc-tagged XP_034431 was not co-immunoprecipiated by anti-Sec34 from lysates prepared from transfected cells (data not shown). 
Direct interaction of Sec34 with ldlBp or ldlCp
Discussion
Sec34, GTC-90, and ldlBp/ldlCp have been independently identified by different approaches.
Sec34 was identified based on a genomic approach to search for the mammalian homologue of Sec34p (20 and this study), which has a well-defined role in ER-Golgi transport in yeast (9-12).
GTC-90 was previously identified as a component of a novel protein complex that participates in intra-Golgi transport using an in vitro biochemical assay (21) . ldlBp and ldlCp were originally identified by a genetic approach (22) (23) (24) (25) and subsequently shown to exist in the same protein complex that regulates Golgi structure and function (28, 30) . One of the most important discoveries of the present study is that Sec34, GTC-90 and ldlBp/ldlCp are components of the same protein complex (s) (we tentatively refer to this as Sec34/GTC-90/ldlBp complex). This is based on several lines of observations. Firstly, GTC-90 and ldlBp (as well as Dor1 and Cod1)
could be efficiently and specifically co-immunoprecipitated from rat liver cytosol by antibodies Furthermore, the inhibition could be neutralized by a non-inhibitory amount of the antigen. We have thus provided evidence that Sec34 plays a similar role in ER-Golgi transport in mammalian cells, although the temporal and other mechanistic aspects of its action remain to be explored.
Although a role for Sec34p or other subunits in intra-Golgi transport in yeast has yet to be investigated, the purification of GTC-90 complex using an in vitro intra-Golgi transport assay suggests that this complex could be intimately involved in intra-Golgi transport (21) . A role for Sec34p in endosome-to-TGN transport has been reported and this was the basis for which Sec34p was independently identified as Grd20p (41) . Although it has been suggested that the role of Sec34p/Grd20p in endosome-to-TGN transport could be due to an indirect effect due to its role in ER-to-Golgi transport (10, 12) , the recent identification of the Sec34p complex and the relatedness of this complex with Ypt6p function indicate that Sec34p/Grd20p complex might have a direct role in endosome-to-TGN transport (32) . Detailed studies of this complex and its individual subunits using genetic, biochemical and cell biochemical approaches in both yeast and mammalian cells will provide additional understanding on its function and mechanism as well as the general organization and regulation of Golgi structure and function. 3-7) . The inhibition exhibited by anti-Sec34 (7 µg) was neutralized by a noninhibitory amount of GST-Sec34/F1 (3 µg) (lanes, 5 and 7) but not by GST (3 µg) (lanes 4 and 6). 
